Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...

The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...

Investors seeking stocks with explosive growth potential should consider the biotech industry. Drugmakers can experience ...

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...

A bespoke CRISPR base-editing therapy designed for a single infant with CPS1 deficiency has produced encouraging early ...

For the scientific enterprise, 2025 was marked by setbacks and challenges. But scientists are no strangers to adversity—the ability to overcome obstacles is built into our training. In turn, research ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Wheat that can help make its own fertilizer is no longer a speculative idea from plant biology textbooks, it is a working ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.